Rating: Neutral | Target Price: RMB 13.2–14.4 (base-case fair value range, midpoint ~RMB 13.8) | Current Price: RMB 13.99 (close on 2026-11-20, 52-week low) | Margin of Safety: -5.6% (current price above the lower bound of the base-case range, no safety cushion) | Time Horizon: 12 months | Currency: RMB
Zhongding Co., Ltd. is the world's No. 8 and China's No. 1 non-tire rubber products automotive parts platform (sealing + vibration damping as the core base; thermal management/lightweight materials/air suspension as growth drivers), with 2025 revenue of RMB 19.800 billion. This report's three key judgments are:
First, true profitability should be measured by non-GAAP net profit: the sharp swings in reported net profit attributable to shareholders (FY2025 +26.98% → first three quarters of 2026 -28.29%) were almost entirely driven by fluctuations in the fair value of financial assets (RMB +475 million → RMB -387 million); non-GAAP net profit grew from RMB 760 million in FY2022 (restated) to RMB 1.081 billion in FY2025, after which growth has stalled year by year—RMB 1.149 billion in the first three quarters of 2026, up only +0.84% YoY, with earnings plateauing at the RMB 1.1 billion level.
Second, the current price is broadly fair: at RMB 13.99, the price sits within this report's base-case fair value range of RMB 13.2–14.4 (midpoint RMB 13.8, -1.4% vs. current price); a non-GAAP TTM P/E of ~16.9x corresponds to near-zero growth, and P/B of 1.23x is at a 5-year low percentile but matches the already-lower non-GAAP ROE (~7.6%). The market is paying roughly 29%–37% of the current price (measure-sensitive) for options on air suspension/robotics/liquid cooling—existing orders are real but incremental momentum is fading (annual air suspension order intake fell from RMB 3.1 billion to RMB 1.4 billion; no new RMB 100-million-level project wins announced in 2025 to date).
Third, timing asymmetry: downside verification catalysts are near (January 2027 earnings preannouncement: Q4 impairment momentum + zero goodwill buffer at AMK/TFH), while upside options are unverified but the game window is also near (convertible bond downward revision time condition met from December 2026, April 2027 annual report disclosure of robotics/liquid cooling revenue, and a dense humanoid robotics sector event period). Overall odds: bear case -30%, base case -1%, bull case +39%; probability-weighted expectation ~-1.9% — Neutral rating, wait for evidence: before seeing the goodwill impairment test in the 2026 annual report and Q4 non-GAAP results, or new air suspension orders / convertible bond revision signals, the current price offers neither sufficient margin of safety to go long nor adequate fundamental evidence to go short.
Opportunity characterization: This is not a "mispriced" stock but an "evidence pending" stock. The share price is down -39% year to date, and the current price is the 52-week low; however, the decline stems mainly from the receding humanoid robotics concept sector (the company fell -6.4%/-9.4% in a single day during the sector-wide slump on 2026-11-16/17), the optically negative Q3 report, and dilution expectations from the RMB 1.92 billion convertible bond—a triple overlap—rather than newly exposed fundamental deterioration; on November 19 the company confirmed via the investor interaction platform that operations are normal with no undisclosed material negatives (Sina Finance stock news, 2026-11-19/20).
Evidence grade and status: Core financial and order data are supported by first-hand financial reports (evidence grade B); the company's current state is a shift from tailwind to headwind for the existing business (overseas revenue stagnation, annual price-down pressure, non-GAAP ROE below cost of equity), while new business options are on the eve of validation—"orders but no revenue."
Possible changes over the next 6–12 months (all on the tracking list): ① The 2026 annual report (expected 2027-04-29) will resolve three things at once—the goodwill impairment test (zero buffer at AMK/TFH), the quality of Q4 non-GAAP earnings, and the first disclosure of robotics segment revenue; ② Whether the annual increment of cumulative air suspension orders can rebound from RMB 1.4 billion (two RMB 100-million-level project wins were announced in each of 2023/2024, none so far in 2025—order recovery is currently an assumption, not a fact); ③ The convertible bond downward revision game (conversion price RMB 18.20, 85% trigger at RMB 15.47, time condition met at the earliest in December 2026).
Ranking of primary price drivers: ① Delivery of the robotics second growth curve × humanoid robotics sector beta (largest elasticity, two-way); ② Rebound in annual air suspension order intake (the sole decisive factor in the base case); ③ Convertible bond downward revision and the conversion-promoting structure (the controlling shareholder self-subscribed RMB 777 million, 40.55% of issuance—deeply aligned interests).
Expectation gap: There is a cognitive divergence of roughly RMB 300–400 million between sell-side consensus (FY2026 net profit ~RMB 1.55 billion, median target price RMB 31.6) and the non-GAAP reality (RMB 1.15–1.23 billion), with the difference almost entirely from assumptions of fair value reversal; consensus EPS has been revised down -6.6% over the past 90 days but still lags significantly behind the halved share price. This report anchors on non-GAAP earnings and estimates the current price implies a non-GAAP ROE recovery to ~10.6% (+42% vs. reality)—expectations are full, not underestimating; excess returns can only come from evidence inflection points in order wins/robotics delivery.
Validation catalysts and falsification conditions: Upside—robotics revenue ≥ RMB 150 million in the 2026 annual report, new RMB 100-million-level air suspension project wins, proposed convertible bond downward revision; Downside—goodwill impairment ≥ RMB 300 million, full-year non-GAAP profit < RMB 1.0 billion, gross margin below 22.5% for two consecutive quarters, share price breaking below RMB 12 combined with rising major-shareholder pledge ratios (see tracking table at end of report).
The non-GAAP measure itself has two impurities requiring two-way adjustment: first, the company has for three consecutive years excluded gains/losses on entrusted external loans (RMB 65/69/80 million) as non-recurring, yet this business carries a balance of ~RMB 910–960 million, normal risk classification, and zero overdue—arguably a recurring treasury management activity; adding it back implies true cash earnings of ~RMB 1.16 billion/year (~7.4% of non-GAAP profit). Second, year-end impairments remain within non-GAAP profit (FY2025 asset impairment losses of RMB 346 million, including RMB 287 million of goodwill impairment), cyclically depressing annual non-GAAP profit via the Q4 impairment cycle. Overall, the sustainable non-GAAP midpoint is ~RMB 1.1–1.2 billion, with ±RMB 200–300 million annual swings; non-GAAP net margin in the first three quarters of 2026 was 7.49%, marginally down from 7.83% in the prior-year period—the "plateau" is in fact "slowly declining margins."
Three qualifications temper the "high quality": ① Weak free cash flow conversion—FY2025 FCF (OCF − capex) of RMB 1.181 billion, FCF/net profit of only 0.74, with capex up +49.5% YoY in FY2025 (company explanation: increased construction-in-progress projects); ② Thin shareholder returns—FY2025 dividend proposal of RMB 1.5 per 10 shares, payout ratio of only 12.4% (FY2023: 23.3%, declining year by year), and management explicitly stated no buyback plans at roadshows; ③ "High deposits alongside high debt"—~RMB 4.7 billion of cash-like assets coexist with RMB 6.6 billion of interest-bearing debt, plus ~RMB 900 million of entrusted loans circulating off the balance sheet; investors questioned this twice and received only boilerplate responses about "coordinated treasury management" (investor relations activity record, 2026-09-17). Non-GAAP ROE of ~7.6% is below the ~9% cost of equity, and ROIC of ~8.2% is broadly flat with WACC (this report's estimates)—the existing business generates no excess returns and cannot support a valuation re-rating.
The current price exceeds the zero-growth economic profit value (EPV ~RMB 8.78/share, sensitivity range RMB 7.8–9.9; normalizing entrusted-loan income into the numerator lifts EPV to ~RMB 9.88), with a residual of ~RMB 4.1–5.2/share (29%–37% of the current price) borne by the air suspension/robotics/liquid cooling options. Note: this residual is a "price minus EPV" measure, highly sensitive to normalization choices, and does not constitute a standalone valuation—supporting evidence for the ~RMB 6.86 billion option premium includes RMB 16.6 billion of cumulative domestic air suspension orders (~14x annual air suspension revenue), 300,000 robotic harmonic reducer units on order, and RMB 43 million of liquid cooling backlog—but the halving of annual order intake and "no new RMB 100-million-level project wins in 2025 to date" mean the option delivery cadence has not yet changed. Conclusion: the current price is fair relative to quality, full relative to options but not a bubble; the base-case fair value of RMB 13.2–14.4 anchors Zhongding's 5-year median P/E (~17.5x, reported basis) discounted to 15–16x on a non-GAAP basis, cross-validated by PB-ROE (1.25 × book value per share of RMB 11.37 ≈ RMB 14.2) and peer ranges (IKD 13x–Tuopu 34x).
Of the total net goodwill of RMB 2.199 billion, the AMK (impaired two years running) and TFH units together carry RMB 1.133 billion of zero-buffer at-risk goodwill, while Precix/WEGU/Germany KACO retain positive test headroom (annual report notes disclose Precix recoverable amount of RMB 853 million vs. carrying value of RMB 661 million, etc.). If European EV slowdown, US tariffs, or customer price-downs force another downward revision of cash flow forecasts (the test discount rate is below this report's own 9% cost of equity), the end-2026 test would trigger additional provisions; impairments are not tax-deductible and hit profit in full. Combined with the January 2027 earnings preannouncement and the April annual report as two disclosure nodes, this forms the clearest binary risk within 12 months. On the convertible bond: the RMB 1.92 billion "Zhongding CB 03" (listed 2026-11-12) has a conversion price of RMB 18.20, 30% above the current price, with full conversion dilution of ~8.0%; the bond's ~75% conversion premium (bond price ~RMB 133 vs. conversion value ~RMB 77) is almost entirely carried by the robotics concept—if the underlying stock does not rise, the premium must converge, and receding concept capital creates long-term pressure.
Three sober calibrations: ① The downward revision is a two-sided event—the proposal announcement is a short-term positive (signaling intent to promote conversion, repairing the bond's option value), but a revision to ~RMB 14 would lift potential dilution from 8.0% to ~10.4%, and the time condition (15/30 days) depends on whether the stock stays below RMB 15.47; a rebound above the trigger invalidates the game; ② Verifiability of robotics delivery is limited—60 OEM units in 2026H1 are only 2% of the planned 3,000-unit annual capacity, the company explicitly refuses to disclose robotics revenue figures, and the annual report may fold this business into the "Others" segment (FY2025 "Others" revenue RMB 2.42 billion)—whether the RMB 150 million threshold can be verified depends on disclosure methodology; ③ Evidence of new air suspension orders is currently zero—two RMB 100-million-level project wins were announced each in 2023/2024 (RMB 340 million and RMB 1.64 billion / RMB 1.418 billion and RMB 757 million), while no RMB 100-million-level air suspension designation announcement has been found for all of 2025 or early 2026—"order recovery" must be evidenced by new announcements. Humanoid robotics sector events (Tesla Optimus V3 mass production launch, MIIT real-scenario training acceptance by end-2026, listing expectations for the two domestic champions) are dense 2027 catalysts, and Zhongding as a high-beta name will amplify them in both directions.
| Metric | FY2023 | FY2024 | FY2025 | 9M 2026 (latest period) |
|---|---|---|---|---|
| Operating revenue (RMB 100M) | 172.44 | 188.54 | 197.998 | 153.35 (+5.36%) |
| Net profit attributable to parent (RMB 100M) | 11.31 | 12.52 | 15.89 | 9.37 (-28.29%) |
| Non-GAAP net profit excl. non-recurring items (RMB 100M) | 9.77 | 10.75 | 10.81 | 11.49 (+0.84%) |
| Gross margin | 21.72% | 22.82% | 23.24% | ~23.9% (Q3 standalone 23.2%, -2.6pp) |
| Net margin (attributable basis) | 6.56% | 6.64% | 8.03% | 6.11% |
| Operating cash flow (RMB 100M) | 14.45 | 17.26 | 21.62 | 12.20 (-2.15%) |
| Free cash flow (RMB 100M, OCF − CapEx, own estimate) | 4.11 | 10.70 | 11.81 | 5.94 (OCF − CapEx 6.26) |
| Cash + trading financial assets (RMB 100M, period-end) | — | 32.99 | 48.50 | 47.14 (as of 2026-09-30) |
| Interest-bearing debt (RMB 100M, period-end) | — | 55.40 | 69.13 | 66.35 (as of 2026-09-30) |
| Net debt (RMB 100M) | — | 22.42 | 20.62 | 19.20 (as of 2026-09-30) |
| Debt-to-asset ratio | 47.05% | 45.98% | 47.37% | 46.31% |
| Goodwill (RMB 100M, period-end) | — | — | 21.44 | 21.99 (14.7% of net assets) |
| Dividend per 10 shares (RMB) | 2.0 (23.3% payout) | 1.5 (plus interim dividend) | 1.5 (12.4% payout) | — |
Note: Balance sheet stock items are taken from the latest period (2026-09-30) as "current values"; certain FY2023/FY2024 stock items are omitted (trend columns based on available data only). See C1 for notes on non-GAAP/non-recurring definitions — entrusted loan income is excluded, while year-end impairments are not.
Drivers of metric changes (items with YoY ≥ ±20%):
Q3 2026 report (disclosed 10-30): 9M revenue RMB 15.335B (+5.36%), non-recurring-excluded attributable net profit RMB 1.149B (+0.84%), attributable net profit RMB 937M (-28.29%); Q3 standalone revenue RMB 5.244B (+11.38%, clear sequential acceleration), non-recurring-excluded RMB 343M (-4.55%), attributable RMB 257M (-47.56%). Standalone gross margin 23.2% (YoY -2.6pp), a signal of annual price-downs and intensifying competition.
Key takeaways: ① Revenue remains solid — Q3 double-digit growth was mainly driven by domestic air suspension/lightweighting volume ramp and a flattening overseas base, consistent with a "stable core, gradually rising incremental" revenue mix; ② The apparent collapse in profit is almost entirely a mirror of the fair value line (-RMB 387M vs +RMB 144M a year earlier); core operations have not stalled; ③ However, the -2.6pp YoY gross margin decline and marginal slip in non-recurring-excluded net margin (7.49% vs 7.83%) show real price-down pressure, not a definitional artifact; ④ vs. sell-side: Guolian Minsheng (2026-11-03, the most conservative of 6 institutions) forecasts full-year attributable profit of RMB 1.37B, implying a Q4 of RMB 433M — versus 2025Q4 attributable profit of only RMB 282M and non-recurring-excluded -RMB 58M; achieving this would rely almost entirely on a fair value reversal and looks difficult. The stock did not crash immediately after the earnings release; the real accelerated decline came two weeks later with the humanoid robot sector correction (11-16/11-17), confirming that this selloff was mainly sector beta, with weak earnings as a secondary factor.
Business model in brief: Asset-heavy automotive components manufacturing + an overseas M&A platform (five global business units). Revenue comes from the lifecycle ramp of designated OEM programs (project-based, non-subscription); bargaining power is neutral-to-weak (rigid annual price-downs, raw material inflation hedged via "strategic reserves + negotiated adjustments," per the company's own description). Traditional sealing/damping (together ~40% of revenue) is the steady cash cow; thermal management/lightweighting/air suspension are the incremental businesses; robotics/liquid cooling is a third-curve narrative (less than 1% of revenue).
Cash content of earnings: OCF/net profit has run 1.28/1.38/1.36 for three consecutive years — genuinely excellent collection quality; FCF/net profit 0.36/0.85/0.74, with the 2025 CapEx pickup absorbing about a quarter of operating cash. Working capital efficiency is high (FY2025 working capital increase only RMB 45M vs revenue increase of RMB 946M, supported by payables/bills), but in 9M 2026 receivables + bills + financing receivables grew +14.1% combined, faster than revenue +5.4% — a marginal deterioration worth tracking.
Recurring earnings test: Of FY2025 attributable profit of RMB 1.589B, RMB 508M was non-recurring (32%), core being RMB 475M of fair value gains — the non-recurring-excluded RMB 1.081B reflects true operating substance. Conversely, the excluded figure also removes RMB 80M of recurring entrusted loan income while retaining RMB 287M of goodwill impairment. After two-way adjustment, "true cash earnings" run roughly RMB 1.16B/year, consistent with the RMB 1.1–1.2B platform judgment.
Return on capital: ROIC ~8.2% (own estimate: EBIT RMB 2.245B × (1 − 22.35% effective tax rate) ÷ invested capital RMB 21.3B), roughly in line with WACC of 8.5%; non-recurring-excluded ROE ~7.6%, below the 9% cost of equity. A sustained sub-8% hurdle rate implies limited incremental returns from acquisitions, integration, and capacity expansion — the serial overseas acquisitions since 2015 (AMK/KACO/TFH/ACUSHNET/WEGU/Precix) built a global footprint, but overseas asset groups' profit contribution keeps weakening.
CapEx quality: Depreciation & amortization details are not separately disclosed; maintenance/growth split unavailable (must be flagged as indeterminable). The CapEx trajectory 1.034 (2023) → 0.656 (2024) → RMB 0.981B (2025) is expansionary (Slovakia in production, Mexico under construction, robotics/liquid cooling lines); incremental returns on new capacity cannot be validated until after 2027. The convertible bond projects (robotic joints RMB 732M + intelligent thermal management RMB 582M) follow the same pattern, and the prior 2019 convertible bond saw 57.89% of proceeds re-allocated in aggregate, with the forged aluminum chassis parts project "failing to reach expected returns" (2026 semiannual special report on raised funds) — the historical record of capital allocation discipline does not support optimism.
Earnings quality red flags: ① Profits at the mercy of financial-asset fair value swings (the 2025 +27% and 2026 -28% share the same source); ② overseas revenue persistently stalled with gross margin of only 18.8%; ③ third-curve revenue contribution tiny (liquid cooling orders RMB 43M, 60 units of contract manufacturing) versus the valuation narrative gap; ④ RMB 900M-scale entrusted-lending quasi-financial business normalized (contributing RMB 65–80M of income for three consecutive years).
Consistency of words and actions: partially delivered, with a preference for qualitative commitments. ① The 2024 annual report outlook of "overall profit to keep recovering and growing, invest prudently" — FY2025 attributable profit +27% but non-recurring-excluded only +0.55%, profit growth driven by fair value gains, while CapEx actually rose +49.5%: "prudent investment" not delivered; ② robotics/liquid cooling "accelerating capacity expansion to secure order delivery" (2025 annual report/roadshows) — liquid cooling orders RMB 38M (2025 annual report) → RMB 43M (2026H1), and the 300,000-unit harmonic reducer order has no disclosed deliveries: hard to verify; ③ the 2019 convertible bond projects "in production and delivering returns" — 57.89% cumulative re-allocation, chassis parts project postponed twice to December 2027: not delivered; ④ the new convertible bond process (launched 2025-12 → approved 2026-08 → roadshow 10-21 → listing 11-12), delivered on schedule. Asked about the 2026 revenue target, management replied "please refer to periodic reports" (2025 annual results briefing Q&A #7) — absence of quantitative guidance is the norm.
Shareholder friendliness: leaning weak. Dividend payout ratio fell three straight years, 23.3% → 21.0% → 12.4%, moving against net profit growth; per-share dividend stuck at RMB 0.15–0.20, with investors directly challenging the "payout ratio below 17%" at the earnings briefing; explicitly no buyback/cancellation plans; a 2016 private placement, a RMB 1.2B convertible bond in 2019, and the new RMB 1.92B convertible bond in 2026 (full conversion dilutes ~8.0%) — refinancing frequency markedly outpaces shareholder-return actions. Undistributed profit of RMB 9.13B sits on the balance sheet.
Risk signals: Controlling shareholder Zhongding Group holds 40.46%, of which 162.5M shares (30.5% of its stake, up from 26.8% at end-2025, ~12.3% of total share capital) are pledged; the Group acquired Bridgestone's damping business first with a promise to "inject it preferentially if profitable" within 60 months — a related-party acquisition pipeline; sole actual controller Xia Yingsong concurrently serves as Chairman + General Manager + Global CEO (after the August 2026 board reshuffle), with highly concentrated decision-making, argued in a dedicated annual report section; no equity incentives/ESOP — a missing tool for aligning management and shareholder interests.
| Segment | Revenue share | Gross margin | GM YoY | Revenue YoY | One-line business logic |
|---|---|---|---|---|---|
| Thermal management (cooling lines) | 24.76% | 18.11% | Slightly down | -3.33% | 3x jump in per-vehicle content for NEV lines, but fiercest domestic-substitution competition |
| Intelligent chassis — rubber damping | 20.99% | 17.34% | — | +2.35% | Bushings/mounts/WEGU absorbers; 2025 new orders RMB 8.3B |
| Sealing systems | 19.60% | 28.32% | Stable | +1.99% | KACO/ACUSHNET high-end sealing; global oligopoly, strongest pricing power |
| Intelligent chassis — lightweighting | 16.41% | 13.40% | — | +29.00% | Ball joints/control arms; Slovakia in production + Mexico under construction; thinnest margins |
| Intelligent chassis — air suspension | 6.01% | 18.04% | -2.07pp | +11.78% | AMK air supply unit + Dingyu air springs; cumulative domestic orders RMB 16.6B |
| Others (molds/equipment, etc.) | 12.22% | 51.41% | — | +3.76% | High-margin supporting business |
| Domestic subtotal | 56.92% (RMB 11.270B) | 26.60% | — | +15.59% | Incremental business landing + localization of overseas technologies |
| Overseas subtotal | 43.08% (RMB 8.529B) | 18.81% | — | -6.31% | Europe/Americas revenue stalled |
Estimating gross profit contribution as revenue share × gross margin: Others (molds/equipment, ~27%) > Sealing (~24%) > Thermal management (~19%) > Damping (~16%) > Lightweighting (~10%) > Air suspension (~5%). Two points worth flagging: the reported "Others" high-margin business (51.4%) contributes the largest single gross-profit block, yet the annual report offers limited disclosure on its sustainability and definition (share of internal supporting use of molds/equipment); the true profit engine with global pricing power is sealing systems — only about a fifth of revenue but nearly a quarter of gross profit, at 28.32% gross margin and stable for years, which is the moat distinguishing Zhongding from purely domestic peers. Air suspension is the growth story but contributes only ~5% of gross profit, with gross margin down 2.07pp YoY — the gap between rapid industry penetration growth (fitted volume +75% range) and the company's +11.78% revenue growth shows its share position in the air suspension chain (ASU subassemblies) is weaker than the three system-integrator leaders (Tuopu/Konghui/Baolong). The spread between the highest (sealing 28.3%) and lowest (lightweighting 13.4%) gross margins reaches 14.9pp: the former is a global oligopoly node built on material formulations and premium customer certification, the latter a competitive aluminum-processing node — within the same company, corroborating the industry-chain logic that "the node determines profit."
Current price RMB 13.99 (2026-11-20 close, this report's price anchor), total shares 1.3165B, market cap RMB 18.418B. Non-recurring-excluded TTM P/E 16.9x (primary anchor; excluded TTM profit RMB 1.091B); P/E (TTM attributable) 15.1x — earnings are unrepresentative (fair value distortion), so this multiple and its percentile are for reference only; P/E (static FY2025) 11.6x, percentile 0%, a distorted figure from one-off-gain-inflated profit, not cited; P/B 1.23x, roughly the 6%–9% percentile over the past 5 years (valuation series definitional differences; the low percentile partly reflects excluded-ROE falling from a reported ~11.6% to ~7.6%; ex-goodwill P/B ~1.44x); P/S (TTM) 0.89x; dividend yield 1.07% (FY2025 RMB 1.5 per 10 shares). Average daily turnover ~RMB 620M, ~3.4% of market cap — liquidity normal, no low-liquidity warning needed.
Triple reverse-engineering: ① EPV residual method — current price = zero-growth EPV of ~RMB 11.56B (RMB 8.78/share) + residual of ~RMB 6.86B (RMB 4.1–5.2/share, 29%–37% of the price, sensitive to normalization choices such as entrusted loan income); ② PB-ROE inversion — P/B 1.23x implies excluded ROE recovering to ~10.6% (excluded profit ~RMB 1.55B, +42% vs TTM RMB 1.091B); ③ vs sell-side consensus (aggregated broker research) — FY2026 attributable profit ~RMB 1.55B (+EPS RMB 1.175), about RMB 300–400M above the excluded-reality range of RMB 1.15–1.23B — the difference being the "fair value reversal" assumption. In one sentence: the current price requires the company to lift excluded earnings from the RMB 1.1B platform to the RMB 1.5B+ scale (or, equivalently, turn fair value items positive), while the reality is excluded growth decelerating from +28.6% to +0.84% over three years and new businesses contributing less than 1% of revenue. This is not bubble pricing — the RMB 16.6B cumulative air suspension orders and the global core business are real assets — but expectations are running full.
| Scenario | Probability | Fair value range | Midpoint vs. current price | Decisive factors |
|---|---|---|---|---|
| Bear | 30% | RMB 9.5–10.0 | -30.3% | Annual price cuts of 10% materialize + large Q4 impairment (AMK/TFH provisions ≥RMB 300 million) + further fair value losses; non-recurring-adjusted profit revised down to RMB 950 million–1.0 billion (EPS RMB 0.72–0.76) × 13x (anchor: Zhongding's 5-year PE low of 11.2x, adjusted upward for non-recurring-adjusted basis; cross-check at PB 3-year low of 1.04x × BPS 11.37 = RMB 11.8, taking the lower) |
| Base | 50% | RMB 13.2–14.4 | -1.4% (midpoint RMB 13.8) | Non-recurring-adjusted profit of RMB 1.1–1.2 billion with slight growth + annual air suspension order intake recovering to RMB 2 billion + fair value drag not widening; exit multiple of 15–16x non-recurring-adjusted (anchor: discount from Zhongding's 5-year median PE of 17.5x on attributable basis to non-recurring-adjusted basis; PB-ROE cross-check at RMB 14.2; positioned toward the lower end of the peer range spanning IGD 13x to Tuopu 34x, rationale: growth and returns slightly below midpoint) |
| Bull | 20% | RMB 18.5–20.5 | +39.4% | Annual air suspension intake back to RMB 3 billion + robotics volume delivery (>100,000 units / new marquee wins) + liquid cooling scaling to RMB 300–500 million; 2027E non-recurring-adjusted profit of RMB 1.35 billion × 19x (44% discount to Tuopu's 34x, reflecting gaps in growth/duration/capital intensity; PB 1.7x 5-year median cross-check at RMB 19.3) |
Probability-weighted fair value ≈ RMB 13.7, expected return ≈ -1.9% — odds are near-symmetric, slightly negative. Upper target of RMB 14.4 is +2.9% vs. current price; lower bound of RMB 13.2 is -5.6% (this figure is this report's margin-of-safety measure: base-case fair value floor is 5.6% below current price, no safety cushion). External benchmarks: median sell-side target of RMB 31.6 (n=11, mostly set when the stock was above RMB 20; stale and distorted, not used as a constraint on scenario ranges); most conservative sell-side, Guolian Minsheng, forecasts attributable profit of RMB 1.37/1.67/1.90 billion for 2026–2028E — even its RMB 1.37 billion implies no further fair value losses, about RMB 200 million above this report's non-recurring-adjusted anchor; this report treats the bear/base scenarios on a non-recurring-adjusted basis and does not adopt its reversal assumption.
In-house earnings forecast (earnings reconciliation anchor):
| Period | Revenue | Non-recurring-adjusted attributable profit | Apparent attributable profit | Key drivers |
|---|---|---|---|---|
| FY2026E | RMB 20.7–21.0 billion (+4.6%~+6%) | RMB 1.15–1.23 billion | RMB 1.2–1.4 billion (fair value direction uncontrollable) | Q4 revenue +3~7%; gross margin 23–24%; Q4 non-recurring-adjusted profit of RMB 0–80 million given impairment momentum |
| FY2027E | RMB 21.6–22.6 billion (+4%~+8%) | RMB 1.25–1.4 billion | RMB 1.35–1.65 billion | Air suspension order recovery (unverified assumption) + robotics revenue of RMB 100–300 million + normalization of annual price cuts |
Management provides no quantitative guidance (explicitly declined to give revenue targets at the earnings briefing); sell-side consensus is FY2026 attributable profit of RMB 1.547 billion / FY2027 RMB 1.909 billion, with differences from the table above mainly in fair value assumptions. If the January 2027 preliminary earnings announcement discloses a large Q4 impairment or full-year non-recurring-adjusted profit <RMB 1.0 billion, this report's base-case scenario will be revised downward accordingly.
Fairly valued (fair): Neither quality (global niche + good cash flow + mediocre returns) nor price (16.9x non-recurring-adjusted, low-percentile PB but declining ROE, option premium of about 30%) shows significant mispricing. Rating neutral: the current price sits within the base-case fair band of ±15%, neither deeply undervalued enough to go long nor with a confirmed de-rating catalyst to go short — the robotics narrative fade has already completed one round of valuation compression (-39%); the next direction will be determined by evidence from the 2026 annual report. Strategically: below RMB 13.2 (under the base-case floor) enters the margin-of-safety zone and is worth re-evaluating for entry; above RMB 14.4 (above the base-case ceiling), the option is fully priced — mind realization discipline.
Aggregate market: In 2025, China's auto production/sales reached 34.531/34.40 million units (+10.4%/+9.4%, CAAM), with NEVs at 16.49 million units (+28.2%); CAAM forecasts 2026 sales of 34.75 million units, only +1% — after the trade-in policy pull-forward, aggregate growth slows and the industry's driver shifts from volume to structure (intelligentization/NEV). There is no unified authoritative headline figure for the auto parts market; reference point: Zhongding ranked 81st on the Automotive News global top-100 parts suppliers list (2026 ranking, up 6 places from the prior year) with 2025 global OEM sales of USD 2.664 billion.
Air suspension (the core incremental track): In 2025, domestic passenger car installations reached 1.272 million sets with a 5.4% penetration rate; at ~RMB 9,500 per vehicle, the market size is ~RMB 12.08 billion; Dongxing Securities projects 1.57 million sets/~RMB 13.4 billion in 2026 and 2.85 million sets/~RMB 20.7 billion by 2030 (2026–2030 installation CAGR ~17%, size CAGR ~11%; sources: CAAM + Gasgoo Research Institute). The 2022–2025 installation CAGR was as high as 75% (238,000 → 1.272 million sets) — penetration rose from ~1% in 2022 to 5.4%, the price band for equipped models has dropped to the RMB 250,000 level, and dual-chamber air spring models' sales share rose from 2.3% in 2023 to 49.3% in the first three quarters of 2025. Thermal management tubing: fuel vehicles ~RMB 200–400 per vehicle for nylon tubing, NEVs 3x or more (~RMB 1,000 per vehicle, extended-range ~RMB 1,500; total thermal management system assembly ~RMB 5,000 per company's 2024 annual report); the NEV thermal management total-vehicle market in 2025 is ~RMB 52.1–90 billion (aggregator-sourced, low reliability, cross-reference only). Sealing/damping: the global automotive sealing market was ~USD 17.1 billion in 2024 (Stratview, tertiary source); the top ten global non-tire rubber products makers had combined revenue of ~USD 26.2 billion (Rubber News list).
Quantified demand-inflection chain (air suspension): Driver trajectory (installations 238,000 → 1.272 million → 2.85M-E sets) × per-vehicle value (~RMB 9,500/set, rising further with dual-chamber share) × penetration ramp (1% → 5.4% → 8.6%-E) × the company's share — the first three links of the chain are complete with first-rate data sources; the weak link is the fourth: the company's domestic air suspension revenue of RMB 1.191 billion (+11.78%) implies ~9.9% exposure (mixed with AMK overseas revenue), and its growth significantly underperforms industry installation growth; among third-party (Gasgoo/Dongxing) domestic system assembly top five suppliers (CR5=99.4%: Tuopu, Konghui, Baolong, WABCO, Continental), Zhongding is absent — the company's true positioning is in ASU (air supply unit) sub-assemblies, with disclosed domestic win lifetime values of ~RMB 3.5 billion cumulative over 2023–2024. Conclusion: the industry demand inflection is real, but the company is a segment-positioned player rather than a system assembly leader; air suspension revenue elasticity depends on share conversion from ASU → air springs → system assemblies.
Upstream: natural rubber, carbon black, steel/aluminum, ECU chips — parts makers have low bargaining power over upstream (Lianhe Credit Rating 2025); raw material price increases cannot be fully passed through, relying on engineering-driven cost reduction as a hedge (per company roadshow: "low-price strategic stockpiling + negotiated price adjustments with customers"). The midstream is being restructured: OEMs adopt a model of "in-house algorithm + suspension ECU development, hardware assembly split into separate awards," tendering air suspension systems by module — air springs, damper assemblies, ASU, air tanks, and sensor sub-assemblies — breaking foreign (Continental/WABCO) full-system monopolies and creating opportunities for sub-assembly suppliers like Zhongding's AMK to supply OEMs directly. Value distribution: air springs + electronically controlled dampers account for over 60% of system cost (thickest value), followed by ASU/air tanks/sensors; bladder (air sleeve) craftsmanship determines air spring durability and cost. Downstream: OEM annual price cuts are rigid (typically 3–5%, harsher in price wars), with profits concentrating among platform-based leading Tier1s; Zhongding's top ten customers (BYD, Volkswagen, Geely, GM, Chery, BMW, Daimler, Ford, Changan, Li Auto) total revenue of RMB 10.506 billion, 53.06% of revenue — customer concentration is upper-medium but the structure includes premium foreign brands, superior to purely domestic chains. Gross margin retention: sealing (28.32%) > air suspension/thermal management (~18%) > damping (17.34%) > lightweighting (13.40%) — material-formulation segments retain the most, machined segments the least.
Three demand drivers: modest volume growth (+1%), NEV penetration (~48% in 2025 → ~57% 2026E), and air suspension trickling down from RMB 300,000+ luxury cars to the RMB 200,000–250,000 mainstream band. Supply side: the three domestic air suspension leaders (Tuopu/Konghui/Baolong) keep expanding capacity; as of end-2025, Baolong holds air spring and system assembly wins of RMB 5.87 billion + ASU RMB 1.3 billion + air tanks RMB 380 million; Tuopu has 15 cumulative wins (mass production for AITO M9, Xiaomi SU7, IM LS6); foreign WABCO/Continental share has shrunk to ~10%. Concentration: domestic air suspension system assembly CR5 = 99.4% (three domestic players combined 89.0%; Konghui led 2024 with 335,000 sets/41.3%); global non-tire rubber products CR3 ~30%+, with Zhongding 8th (Rubber News). Entry barriers: for air suspension — bladder material craftsmanship, electronically controlled damper solenoid valves (previously monopolized by RAPA/Kendrion, now being broken by domestic players), ASU compressor technology (AMK's accumulation since the 1990s), and automotive safety-part certification cycles; for sealing — material formulations + global simultaneous-development qualifications + premium customer certification. Competitive intensity: highest in air suspension — after domestic substitution overtook imports, system prices have fallen below RMB 10,000 and 2026 annual price cuts are expected at 10% (Dongxing), turning the "substitution dividend" into "cost involution"; sealing/damping is moderate with a fixed landscape. Substitution threat: fully active suspensions (hydraulic/motor type, e.g., BYD Yangwang-P) are projected at 590,000 sets by 2030 — both an upgrade and a diversion for traditional air suspension. In 2025, comparable companies' gross margins broadly declined (Tuopu -1.37pp, Baolong -3.97pp, Zhongding air suspension -2.07pp) — a complete evidence chain of OEM price wars transmitting to parts suppliers via annual price cuts.
Aggregate cycle: after 2025's record production/sales, a plateau period begins (2026E +1%); the pull-forward effect of policy (trade-in/halved purchase tax) must be discerned in early-2027 data. Structural cycles: air suspension in early-to-mid growth (5.4% penetration), thermal management in mid-growth, sealing/damping in maturity — Zhongding is a combination of "mature cash flow + growth options." Leading indicators: monthly air suspension penetration, cadence of OEM win announcements, NEV penetration rate, speed of price-band descent, rubber/steel-aluminum prices, quarterly parts gross margins. Regulation and policy: US Section 232 tariffs of 25% on imported auto parts are normalized (from 2025-05; IEEPA rate on China cut to 20% on 2025-11, expiring 2026-02), USMCA-compliant exemptions; Zhongding's overseas revenue is mainly Europe, with localized production across Asia/Europe/Americas (capacity share 68.4%/22.6%/9.0%); direct US exposure not separately disclosed — neutral to manageable but requiring monitoring. Robotics/embodied AI policy is significantly positive: first written into the Government Work Report in 2025; MIIT's Guidelines for Innovative Development of Humanoid Robots target an self-reliant industry chain by 2027; the 2026 MIIT+SASAC real-world training special initiative (year-end acceptance, 100 high-value scenarios); Beijing targets 10,000 units deployed by 2027 — Zhongding's chain-leader position in Hefei benefits from local support.
| Company | Revenue (RMB bn) | Revenue growth | Gross margin | ROE (weighted) | Market cap (RMB bn) | Key differentiators |
|---|---|---|---|---|---|---|
| Tuopu Group | 29.581 | +11.21% | 19.43% (-1.37pp) | 12.73% | ~84.2 | Tier0.5 platform, tied to Tesla + Seres; top-three air suspension assemblies + robotics actuator narrative |
| Baolong Technology | 8.747 | +24.52% | 21.08% (-3.97pp) | 6.60% (2025 attributable profit RMB 213 million, -29.7%) | ~9.6 | Direct air spring rival, ASU latecomer; revenue growth without profit, trading price for volume |
| IGD | 7.413 | +9.89% | Not available (net margin ~16%, highest of the three) | 13.03% | ~12.8 | Aluminum die-casting niche leader, global customers, highest net margin |
| Zhongding | 19.800 | +5.02% | 23.24% | 11.62% (apparent; ~7.6% non-recurring-adjusted) | 18.42 | Global non-tire rubber #8 / domestic #1; 43% overseas revenue; air suspension positioned in ASU sub-assemblies |
Benchmarking conclusion: Zhongding leads in scale and gross margin (thanks to its global sealing base), but has the lowest growth (+5.02% vs. Tuopu +11.2%/Baolong +24.5%) and its apparent ROE contains fair value fluff; its valuation (PE 15.1x) sits between IGD (13x, high growth and net margin) and Tuopu/Baolong (34–36x, robotics narrative premium) — the market positions Zhongding as "steady but unexciting," consistent with this report's judgment of "fair quality, option fully priced." IGD is the best reference for Zhongding's valuation ceiling: a pure manufacturer with faster growth and higher net margin trades at only 13x.
Dual positioning: global niche oligopoly + second-tier domestic intelligent chassis player. The base business (sealing + damping, ~40% of revenue) holds a solid global oligopoly position — Rubber News #8 / domestic #1 (third-party and company self-reported figures agree), sealing gross margin of 28.32% a rare high-profit segment in the industry, customers including Volkswagen/BMW/Daimler; share trend: global top-100 ranking rose continuously to 81st. Air suspension positioning is unique but awkward: the company claims AMK is "a top-three premium supplier in air suspension systems" (global premium basis), while third-party domestic installation data shows no Zhongding among the system assembly CR5; its true position is domestic ASU main supplier + air spring chaser — the two bases coexist, the difference stemming from statistical scope (system assembly sourcing vs. sub-assembly supply); investors should not conflate them. Share trend: 2025 air suspension revenue +11.78% underperformed industry installation growth (+75% → ~+23% 2026E), implying share pressure. Thermal management is sizable (RMB 4.9 billion) but 2025 revenue fell -3.33%, defensive in the domestic substitution contest. Moat sources: rubber material formulations and global simultaneous-development system (acquired technology assets + Chinese engineer dividend driving cost down), tri-continental localized production and premium customer certifications, and a financial structure of "mature-business cash flow funding new tracks." Upside elasticity depends on share conversion from ASU → assemblies and realization of the robotics/liquid-cooling second curve; downside risk is sustained compression of sub-18% gross margin businesses by annual price cuts and price wars.
The generic financial framework for auto parts misses three decisive variables, and Zhongding embodies all three:
① The lifetime order book is a leading indicator of revenue. Company disclosures: cumulative domestic air suspension orders of RMB 12.1 billion (end-2023) → RMB 15.2 billion (end-2024) → RMB 16.6 billion (end-2025) — annual increments of RMB 3.1 → 1.4 billion, halved; thermal management annual new orders 120 → 117 → 116, declining slightly each year; lightweighting annual orders RMB 14.2 billion (2024) → RMB 10.7 billion (2025); damping RMB 8.3 billion, sealing RMB 3.9 billion (annual 2025). Total 2025 new orders ~RMB 34.5 billion (per earnings briefing). The order book stock covers annual revenue by a high multiple (air suspension RMB 16.6 billion vs. annual air suspension revenue of RMB 1.19 billion ≈ 14x), meaning revenue has a reservoir — but the replenishment rate (annual increment) determines the growth slope: with the annual increment halved while revenue still grew +11.78%, current revenue ramp-up is drawing on the stock of the high-growth orders from 2023–2024; 2027–2028 revenue growth will converge toward the RMB 1.4 billion/year order increment unless large new orders resume. RMB 100-million-level win announcements are the only monthly verifiable signal: 2 in 2023 (RMB 340 million / 1.64 billion), 2 in 2024 (RMB 1.418 billion / 757 million), 0 in 2025, and 0 so far in 2026.
② Per-vehicle value (ASP) expansion is the underlying logic of parts growth stocks. Fluid tubing: ~RMB 300/vehicle in traditional vehicles → nearly RMB 1,000 in NEVs → ~RMB 1,500 for extended-range; thermal management system assembly ~RMB 5,000/vehicle; air suspension system assembly ~RMB 4,113/vehicle (per company's 2025-11 win announcement) — intelligentization + electrification lifts the company's addressable per-vehicle value from hundreds to thousands of yuan. The Zhongding narrative = 5–10x per-vehicle value expansion × share retention, but 2025 data only validated the first half.
③ Annual price cuts and raw material pass-through determine the profit-margin ceiling. Industry annual price cuts are typically 3–5%, with air suspension expected at 10% in 2026; the company's hedges are low-price strategic raw material stockpiles and negotiated price adjustments (roadshow basis), but the -2.6pp year-over-year single-quarter gross margin drop in 2026Q3 proves pass-through is incomplete. Overseas capacity (AMK/WEGU/KACO in Germany, TFH in France, ADG in Austria, ACUSHNET in the US, Slovakia in production, Mexico under construction, Brazil/Malaysia bases) is both a moat and a burden in the tariff era — overseas gross margin of 18.8% persistently below domestic 26.6%, European base revenue stagnant while new Slovak/Mexican capacity still ramps; "globalized capacity" drags on returns short-term but hedges tariffs long-term.
Overall Rating: Neutral (12 months, confidence 0.55). Zhongding Co. is the global niche leader in rubber sealing parts, with genuine receivables quality and a solid business base; however, its RMB 1.1 billion ex-non-recurring earnings platform has seen growth fall to zero, capital returns merely match the cost of capital, shareholder return willingness is weak, and the income statement is repeatedly manipulated by two major items: fair value changes of financial assets and year-end impairments. The current price of RMB 13.99 (close on 2026-11-20, a 52-week low, -39% YTD) has already digested one round of robot concept ebbing, falling within the baseline fair range of 13.2–14.4 yuan — fairly valued, with no margin of safety, yet also no bubble; odds are nearly symmetric (bear -30%/baseline -1%/bull +39%, probability-weighted approximately -1.9%), and it is unpredictable whether downside risk will be validated first (January 2027 earnings preannouncement) or the upside option will be exercised first (December 2026 convertible bond downward revision window, robotics sector events). The optimal strategy is to hold and observe, reassess entry below 13.2 yuan, and enforce profit-taking discipline above 14.4 yuan.
Strategy and Risk Warnings: Three downside nodes — the 2027-01 earnings preannouncement (Q4 impairments), the 2026 annual report goodwill test (zero buffer at AMK/TFH), and convertible bond supply after the conversion period opens on 2027-04-28; three upside options — the pending hundred-million-yuan-scale new order wins, robotics revenue ≥ RMB 150 million in the annual report, and a convertible bond downward revision proposal. Key risks: goodwill impairment beyond expectations (RMB 2.199 billion, 12% of market cap), further losses in fair value items (balance still at RMB 606 million), annual price cuts breaking through gross margin, negative feedback from the controlling shareholder's pledge (30.5% of its holdings) as the share price declines, and falsification of the robotics narrative.
Monitoring Conditions (Falsification/Catalysts): ① Goodwill impairment ≥ RMB 300 million or full-year ex-non-recurring earnings < RMB 1 billion — breaches the ex-non-recurring platform assumption, shifting to bear-case reassessment; ② Pending order annual increment < RMB 1 billion with no hundred-million-yuan-scale new order wins — option support invalidated; ③ Quarterly gross margin below 22.5% for two consecutive quarters — deterioration of the business base; ④ Share price falls below RMB 12 alongside a rising major shareholder pledge ratio — governance negative feedback; ⑤ Upside: reassess option pricing if the share price recovers above RMB 14.4 (upper bound of the baseline range), re-evaluate entry if it falls below RMB 13.2 (lower bound of the range); ⑥ First disclosure of robotics/liquid cooling revenue in the 2026 annual report, convertible bond downward revision proposal, announcements of controlling shareholder share increases or buybacks, humanoid robotics industry events (MIIT training validation/Optimus mass production/IPOs of the two domestic champions).
Report date: 2026-11-20|Price anchor: RMB 13.99 (close on 2026-11-20, completed_close)|The valuation estimates, scenario analyses, and earnings forecasts in this report are research opinions, not investment advice; cited data should be based on company announcements and noted sources.
<!-- publication:aaae4d5a3a057b6b1cf088eb -->